收藏切换
The clinical effects of levosimendan in children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery
收藏切换
Wenjing WANG, Tinglin WU*
World Clinical Drug | 2023, 44(6) : 594 - 598
Less
收藏切换
World Clinical Drug | 2023, 44(6): 594-598
• Article •
The clinical effects of levosimendan in children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery
Full
Wenjing WANG, Tinglin WU*
Affiliations
  • Department of Pediatrics, the People's Hospital of Dazu, Chongqing, Chongqing 402360, China
Published: 2023-06-10 doi: 10.13683/j.wph.2023.06.013
Outline
收藏切换
Objective

To explore the clinical effects of levosimendan on children requiring veno-arterial extracorporeal membrane oxygenation (VA-ECMO) after cardiac surgery.

Methods

Children who underwent cardiac surgery in the department of pediatrics, Dazu district people's hospital of Chongqing from January 2016 to October 2021, and needed VA-ECMO support after surgery and tried to quit ECMO were selected and were divided into levosimendan group (n=43) and control group (n=52). Dual robust estimation method was used to balance study covariates, including baseline characteristics, vasoactive inotropic score (VIS), the risk adjustment in congenital heart surgery-1 method (RACHS-1), and further adjustment of the final model according to the duration of ECMO. Kaplan-Meier method was used to estimate the survival rate 30 days after intubation, and log-rank test was performed.

Results

The duration of ECMO operation in levosimendan group was longer than that in control group, and the difference was statistically significant (P<0.001). The offline failure rates of levosimendan group and control group were 4.65% and 21.15%, respectively, and the difference was statistically significant (P<0.05). After regression adjustment for ECMO duration, the levosimendan group had a lower risk of offline failure [adjusted relative risk (95% confidence interval): 0.20 (0.07 to 0.57)] and a lower risk of hospitalization death [adjusted relative risk (95% confidence interval): 0.45 (0.26 to 0.76)] than the control group. Kaplan-Meier survival curve showed that the 30-day survival rate of levosimendan group was higher than that of control group (88.37% vs 65.38%, P<0.001).

Conclusion

Levosimendan therapy can reduce the risk of off-line failure and in-hospital mortality in children requiring VA-ECMO after cardiac surgery.

levosimendan  /  cardiac surgery  /  extracorporeal membrane oxygenation  /  risk of offline failure  /  in-hospital mortality
王文静, 伍庭林. 左西孟旦对心脏手术后需静脉-动脉体外膜氧合患儿的临床效果研究. 世界临床药物, 2023 , 44 (6) : 594 -598 . DOI: 10.13683/j.wph.2023.06.013
Wenjing WANG, Tinglin WU. The clinical effects of levosimendan in children requiring veno-arterial extracorporeal membrane oxygenation after cardiac surgery[J]. World Clinical Drug, 2023 , 44 (6) : 594 -598 . DOI: 10.13683/j.wph.2023.06.013
Year 2023 volume 44 Issue 6
9
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.06.013
  • Receive Date:2022-08-27
  • Online Date:2026-11-18
  • Published:2023-06-10
Article Data
Affiliations
History
  • Received:2022-08-27
  • Revised:2023-03-12
Affiliations
    Department of Pediatrics, the People's Hospital of Dazu, Chongqing, Chongqing 402360, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.06.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT